Figure 5.

Direct effect of RBP4 on human SVF‐derived adipocytes leads to increased basal lipolysis (A) but does not impair the ability of insulin to inhibit lipolysis (B, C). A, Human SVF‐derived adipocytes were incubated with RBP4 (50 µg/mL) for 3 or 18 hours, *P < .01 versus all other conditions. B, After RBP4 incubation, a dose‐response to insulin of 8‐Bromo‐cAMP‐activated lipolysis was performed. C, Results in panel B are expressed as % of maximal 8‐Bromo‐cAMP‐activated lipolysis